279 related articles for article (PubMed ID: 12568298)
1. Hodgkin's lymphoma and CD30 signal transduction.
Horie R; Higashihara M; Watanabe T
Int J Hematol; 2003 Jan; 77(1):37-47. PubMed ID: 12568298
[TBL] [Abstract][Full Text] [Related]
2. The biological basis of Hodgkin's lymphoma.
Horie R; Watanabe T
Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
[TBL] [Abstract][Full Text] [Related]
3. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
Lee IS; Kim SH; Song HG; Park SH
Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T
Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717
[TBL] [Abstract][Full Text] [Related]
7. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
8. IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.
Watanabe M; Dewan MZ; Taira M; Shoda M; Honda M; Sata T; Higashihara M; Kadin ME; Watanabe T; Yamamoto N; Umezawa K; Horie R
Lab Invest; 2007 Apr; 87(4):372-82. PubMed ID: 17310217
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
[TBL] [Abstract][Full Text] [Related]
10. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
[TBL] [Abstract][Full Text] [Related]
11. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Nonaka M; Horie R; Itoh K; Watanabe T; Yamamoto N; Yamaoka S
Oncogene; 2005 Jun; 24(24):3976-86. PubMed ID: 15782119
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.
Emmerich F; Meiser M; Hummel M; Demel G; Foss HD; Jundt F; Mathas S; Krappmann D; Scheidereit C; Stein H; Dörken B
Blood; 1999 Nov; 94(9):3129-34. PubMed ID: 10556199
[TBL] [Abstract][Full Text] [Related]
13. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
[TBL] [Abstract][Full Text] [Related]
14. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
[TBL] [Abstract][Full Text] [Related]
16. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
Hsu PL; Hsu SM
Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
[TBL] [Abstract][Full Text] [Related]
17. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms of classic Hodgkin's lymphoma.
Felberbaum RS
Yale J Biol Med; 2005 Jul; 78(4):203-10. PubMed ID: 16720015
[TBL] [Abstract][Full Text] [Related]
20. Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines.
Watanabe M; Nakano K; Togano T; Nakashima M; Higashihara M; Kadin ME; Watanabe T; Horie R
Oncol Res; 2011; 19(10-11):463-9. PubMed ID: 22715589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
